(Total Views: 219)
Posted On: 04/12/2018 3:39:30 PM
Post# of 72445
All that does is screw trials up.
To the extent the placebo group has a better response than they should, this makes it harder for the experimental group to show a statistically significant benefit over the placebo or SOC group.
That in turn makes it harder to approve the drug at the FDA.
That will ultimately either deprive more people of the benefit of the drug long-term if it is never brought to fruition or cause the company developing the drug to have need for more funds.
The latter may cause the company to go into bankruptcy or to sell out cheaply.
AHA, now we have the reason people try to screw up studies.
To the extent the placebo group has a better response than they should, this makes it harder for the experimental group to show a statistically significant benefit over the placebo or SOC group.
That in turn makes it harder to approve the drug at the FDA.
That will ultimately either deprive more people of the benefit of the drug long-term if it is never brought to fruition or cause the company developing the drug to have need for more funds.
The latter may cause the company to go into bankruptcy or to sell out cheaply.
AHA, now we have the reason people try to screw up studies.
(2)
(0)
